Epipen e z pen side effects by duration, gender and age - a phase IV clinical study of FDA data


Side effects are reported by people who take Epipen e z pen. Common side effects include drug ineffective among females and drug ineffective among males.

The phase IV clinical study is created by eHealthMe based on 2 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 12, 2023

2 people who take Epipen E Z Pen and have side effects are studied.

What is Epipen E Z Pen?

Epipen e z pen has active ingredients of epinephrine. eHealthMe is studying from 10 Epipen e z pen users for its effectiveness, alternative drugs and more.

Number of Epipen e z pen reports submitted per year:

Epipen e z pen side effects.

Epipen E Z Pen side effects by gender *:


  1. Drug ineffective


  1. Drug ineffective

Epipen E Z Pen side effects by age (0-1 to 60+) *:










  1. Drug ineffective







* Approximation only. Some reports may have incomplete information.

Do you take Epipen e z pen?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on epinephrine (the active ingredients of Epipen e z pen) and Epipen e z pen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Epipen e z pen:

All Epipen e z pen side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: